To study the effects of alveolar hypoxia on canine bronchopulmonary shunt flow, a biventricular bypass preparation was employed. The preparation allowed a constant and sensitive measure of changes in pulmonary venous blood flow. In 16 of 18 dogs with intact bronchial arteries, alveolar hypoxia caused an increase in pulmonary venous return both under conditions of constant pulmonary arterial inflow and under conditions of no pulmonary arterial inflow, suggesting bronchopulmonary shunting. This effect was accompanied by systemic vasodilation despite vagotomy and ganglionic blockade, and was abolished by division of all bronchial vessels. Ibuprofen, 3 mg/kg, and indomethacin, 15 mg/kg, in dogs with intact bronchial vessels, abolished both the increase in pulmonary venous return and the systemic vasodilatation caused by hypoxia. Thus, alveolar hypoxia directly augments bronchopulmonary flow, most likely through release of one or more vasodilating prostaglandins.
Introduction
The vasoconstrictor response of the pulmonary vasculature to alveolar hypoxia is now well established, and clarification ofthe mechanism of the response is slowly evolving (1, 2) . The effects of alveolar hypoxia on the bronchial circulation, however, have not been well characterized. In particular, possible effects on bronchopulmonary anastomotic flow have not been adequately described.
In order to study the effects of alveolar hypoxia on bronchopulmonary shunt flow, all independent variables affecting this flow must be considered and, where possible, controlled. The major hemodynamic and neural determinants of bronchopulmonary flow have been studied by several groups over the past four decades. The majority of investigators (3) (4) (5) (6) (7) (8) (9) have found that systemic arterial pressure, independent of cardiac output, is one of the principal factors determining bronchopulmonary shunt flow. Although the exact anatomic location of the connections between the bronchial and pulmonary circulations is a subject of some controversy (10, 1 1), all agree that the pulmonary arterial and venous pressures, reflecting the "outflow pressure" ofthe bronchopulmonary anastomoses, are also principal determinants. Systemic venous pressure, as a determinant of the outflow pressure of the bronchial veins, can modify the fraction of bronchial arterial blood that flows into the broncho-pulmonary anastomoses (5, 6) . Increasing intrapulmonary pressure and positive end-expiratory pressure can decrease bronchopulmonary flow independent of primary changes in intravascular pressures (7, 9, (12) (13) (14) (15) . Sympathetic nerve stimulation has been shown to decrease total bronchial arterial flow (12, 16, 17) even though it may increase bronchopulmonary shunt flow (presumably through constriction of bronchial veins) (17) , whereas vagal stimulation increases total bronchial flow with unknown effects on bronchopulmonary flow (7, 12) .
Control of systemic blood gases is also important, because their effects on the bronchial circulation are not clear. Systemic hypoxemia has been reported to increase (18) (19) (20) or decrease (21, 22) total bronchial flow, and systemic hypercarbia has been reported to increase (12, 19, 22) , not change (5), or decrease (21) bronchial flow.
Previous studies of the effects of alveolar hypoxia on the bronchial circulation are limited and conflicting. Bruner and Schmidt (12) reported that alveolar hypoxia increased total bronchial arterial flow in open-chest dogs, whereas Baile and Pare (22) found the opposite effect; neither group studied bronchopulmonary shunt flow. Williams and Towbin (4) found that alveolar hypoxia slightly decreased bronchopulmonary flow in one intact dog and in two whose left pulmonary artery had been ligated months before; Lilker anSd Nagy (18) then reported that alveolar hypoxia increased the bronchial flow taking part in gas exchange in dogs several months after left pulmonary artery ligation.
The bronchial circulation is thought to serve primarily as a source of nutrition for the lung parenchyma as well as for the bronchi. In conditions such as consolidation, alveolar edema, and atelectasis, in which the alveolar structures are deprived of inspired gases, the only sources of oxygen are mixed venous and bronchial arterial blood. Because there is only a limited amount of oxygen available for use in mixed venous blood, it might be reasoned that during alveolar hypoxia the bronchial flow to the pulmonary parenchyma should increase. In particular, that portion of bronchial arterial flow that supplies the most distal portions of the bronchial and pulmonary vascular trees-the bronchopulmonary anastomotic flow (10, 11)-should increase.
The object of the present study was to examine the effects of alveolar hypoxia alone, independent of changes in systemic hemodynamics, systemic blood gases, and neural effects, on the bronchopulmonary anastomotic flow in the lungs of normal dogs. A Therefore the LA pump and the LA reservoir were placed on a stand the height of which off the floor could be continuously varied with an automobile jack to maintain constant the relation among the heights of the blood level in the LA column, the LA pump, and the left reservoir.
The afterload and preload sensitivities of the PA pump, on the other hand, were found not to be significant over the range of PA pressures and right reservoir volumes encountered.
Approximately 5 liters ofblood obtained from two large donor dogs was used to prime the perfusion system. Additional chloralose and urethane (up to a total of 150 and 1,500 mg/kg, respectively) were administered after initiation of bypass. Whenever additional anesthetic was added, a period of at least 30 min was allowed for equilibration before All vascular pressures were monitored via saline-filled 19-gauge butterfly tubing (Abbott Laboratories, Inc., North Chicago, IL) 15 cm in length, connected to Gould disposable pressure transducers (Gould Inc., Oxnard, CA). The PA pressure line was inserted through a purse string in the main PA 1-2 cm distal to the tip of the perfusion cannula. The aortic pressure line was inserted through the left internal mammary artery into the aortic arch, and the left atrial pressure line was inserted through the tip of the atrial appendage. Airway pressure was monitored with a transducer directly connected to a side hole in the endotracheal tube. All pressures were continuously recorded on a Hewlett-Packard 7700 eight-channel recorder (Hewlett-Packard Co., Palo Alto, CA).
Cervical vagotomy was accomplished in all animals by simple transection of both vagus nerves -5 cm below the level of the thyroid. Ganglionic blockade, when used, was produced by the administration of 5 mg/kg mecamylamine into the perfusion system. Ibuprofen, 3 mg/kg (as sodium ibuprofenate) was given to four dogs by infusion into the right reservoir over 10 min. (Ibuprofen was kindly supplied by Upjohn Co., West Sussex, England). Indomethacin (crystalline, Sigma Chemical Co., St. Louis, MO), 15 mg/kg, dissolved in 100 ml of phosphate buffer at pH 8, was given to two other dogs by the same route. Drugs were infused into the PA with a Harvard infusion pump just proximal to the PA pump so that the infusion flow would not alter the total PA flow rate.
In six dogs the bronchial vessels were divided and all collateral sources of bronchopulmonary blood flow were eliminated by careful dissection ofthe posterior mediastinum through a right thoracotomy prior to median sternotomy. The distal 8 cm oftrachea, the carina, and the bronchi were separated from all posterior structures. The trachea was circumferentially isolated just above the carina, and the pleuropericardial reflections on the hila were divided with electrocautery. Assessment ofthe completeness of the elimination of bronchopulmonary flow was made at the end of the experiment in five of these dogs by infusing silastic under a pressure of 150-200 mmHg into the thoracic aorta after clamping the arch vessels and the descending aorta at the diaphragm. In two of the five dogs a very small amount of silastic was found to pass into the left upper lung lobe through tiny pleural vessels that had escaped division. In the remainder there was no silastic found in the lung parenchyma, and in none of the five was any silastic found in the main PA or the LA. In contrast, in two dogs whose bronchial vessels were intact, there was extensive filling of the lung vasculature with silastic, and large amounts of silastic were found in both the main PA and the LA.
At the end of each experiment a careful dissection of the lungs and heart was performed. No cases of patent foramen ovale, patent ductus, or any other abnormal systemic-pulmonary or left heart-right heart communication were found.
In order to estimate the total pulmonary intravascular blood volume, in four dogs the systemic circulation was discontinued, and I min later the PA and LA pumps were simultaneously stopped. The PA cannula was cross-clamped at its entrance into the RV outflow tract at the same time. Then air was gently blown into the main PA via the PA pressure catheter to displace any remaining intravascular blood. After correcting for the volume of blood contained in the LA, LV, and LA drainage cannula, the amount of blood drained into the LA column during this maneuver represented a gross estimate of pulmonary blood volume.
Statistical analysis ofthe changes in blood gases with alveolar hypoxia (Table I) was done using a two-sample, single-tailed t test. Statistical significance of the changes in PA and aortic pressures and LA return was determined by analysis of variance and covariance from an extrapolated baseline. Straight lines were fit to the 11 distinct, equally spaced points in each 10-min control period, and variances in the estimated regression lines were computed for each minute post control. The standard estimate for variances in the prediction of a population regression line was employed (23) . These minute-by-minute variance estimates, which result in hyperbolic confidence belts around the regression lines, were then pooled across all the experimental runs for each intervention at each minute using the standard method for pooling variance estimates from independent sources (23) . The pooled minute-by-minute variance estimates were then used to construct confidence limits (i.e., ± I SEM) about the x-axis of hypothetical zero change in the parameter under study. At minutes 4, 5, and 10 the variances thus estimated were added to the variance about the experimental curves at the same time points to construct a two-sample, double-tailed I test of the null hypothesis of zero change of the experimental parameter. Significance was assumed only if P < 0.05.
Results
In 16 of the 18 dogs with intact bronchial vessels, ventilation with an hypoxic gas mixture caused an increase in LA flow that persisted as long as the hypoxic mixture was administered. A recorder tracing from a representative experiment is shown in Fig. 2 , and the mean data from all experiments are shown in Fig. 3 . In all figures, the slopes ofthe LA return curves represent the LA flow rates relative to the control periods: a positive slope reflects a relative increase, and a negative slope a relative decrease, in LA flow rate. The LA flow began to rise usually within 1-2 min of changing the inspired gas from high to zero F102 (fractional concentration of oxygen in the inspired gas). It took 0.5-1 min for the LA blood P02 to fall below systemic venous levels, probably owing to the time required for alveolar gas mixing, but by 1.5 min this level had been reached in all cases (see Table I ). The LA flow rate increased by a mean of 3.5±0.7 ml/min (range 1.2-1 1.1 ml/min) (P < 0.001), shown by the increase in slope of the LA return curve in Fig. 3 from the control slope of zero. It remained elevated for the entire period of alveolar hypoxia, regardless of the absolute duration, for all times studied (10-25 min). Fig. 3 shows the mean data from the first 10 min of each experiment, in that 10 min was the minimum duration of hypoxia studied. Fig. 4 shows the results from a trial lasting 25 min: note that the LA return curve retains its positive slope for the entire period of hypoxia. As Figs. 2-5 , and held true with control PA pressures ranging from 8 to 16 mmHg. In that LA pressure and PA flow were held constant, this indicated that there was no significant pulmonary vasoconstriction.
Because the hypoxia-induced increase in LA flow and systemic vasodilatation were unassociated with any significant pulmonary hypoxic pressor response, the presence of a circulating vasodilating substance was suspected. Therefore four dogs were given ibuprofen, 3 mg/kg, into the right (systemic venous) reservoir. As shown in Table II , ibuprofen administration alone caused both the PA and systemic arterial pressures to rise steadily over 20 min, while the LA flow rate decreased. Furthermore, as shown in Fig. 7 , alveolar hypoxia after ibuprofen caused a significant rise in PA pressure in all dogs (P < 0.002), accompanied by a lack of significant effects on both LA flow and systemic arterial pressure (NS). Again there was no detectable effect on intratracheal pressure. To make certain that these were not nonspecific effects of ibuprofen, indomethacin, 15 mg/kg was given to an additional two dogs in the same manner, with the same result. The data from a single trial before, and from a single trial after indomethacin obtained from one of these dogs are shown in Fig. 8 ; the results from all the other trials (a total of four trials before and four trials after indomethacin) in both dogs are similar to those shown.
The effects of ganglionic blockade were examined by comparing the results obtained in eight dogs without mecamylamine to those in the other eight with mecamylamine. As shown in Table III , there were no signficant differences between the two groups in either LA flow changes or systemic arterial and PA pressure changes.
The effects of increasing inspired Pco2 in addition to decreasing Po2 were examined by comparing the results obtained in three dogs with 95% N2/5% CO2 as the hypoxic gas mixture with the remainder in which 98% N2/2% CO2 was used. (The systemic blood gases were kept constant by varying the gas flows through the oxygenator as needed.) Again, as shown in Table   Table II IV, there were no significant differences in PA pressure, arterial pressure, or LA flow changes.
The effects of "cardiac output" were examined by increasing the perfusion rate in both the pulmonary and systemic circuits by 70% in two dogs with the bronchial vessels intact. As shown in Table V , increasing the perfusion rates increased the magnitude of the change in LA flow induced by alveolar hypoxia.
To demonstrate that the LA flow changes caused by alveolar hypoxia represented changes in bronchopulmonary shunt flow, the bronchial vessels and all collateral communications between the systemic and pulmonary circulations were divided prior to biventricular bypass in six dogs; the results are shown in Fig. 9 . Alveolar hypoxia in these animals caused no significant change in LA flow rate (NS). Of interest, there was also less systemic vasodilatation than in animals with intact vessels, although there was the same lack of significant pulmonary pressor response.
Further evidence supporting the hypothesis that alveolar hypoxia causes an increase in bronchopulmonary shunt flow was obtained by simultaneously turning off the PA and LA pumps while maintaining the systemic circulation intact. This was done by simultaneously switching offthe PA and LA pumps, clamping the PA perfusion cannula, and pumping the systemic venous return from the right reservoir directly into the left reservoir/oxygenator. Under these conditions, after the first minute during which the pulmonary vessels drain most of the blood contained within them, persistent LA blood flow must represent systemic to pulmonary blood flow, i.e., bronchopulmonary shunt flow (in the absence ofcoronary flow and any abnormal systemicto-pulmonary communications). As shown in Table VI , in six dogs with intact bronchial vessels, the LA return after turning offthe PA and LA pumps-i.e., bronchopulmonary anastomotic flow-was 29±5% greater after 10 min of alveolar hypoxia than Table II. during high 02 ventilation (P < 0.05). In four of these, ibuprofen administration not only decreased this persistent LA flow compared with control, but it also abolished the difference between the LA flow with alveolar hypoxia and that with normoxia (NS); the same effects were produced by indomethacin in two dogs (Table VII) . In three dogs whose bronchial vessels had been divided, there was no persistent LA flow after turning off the PA and LA pumps, with either alveolar hypoxia or control.
As a rough estimate of the total pulmonary intravascular volume, the volume emptied into the LA column after simultaneous stopping the PA and LA pumps (after prior arrest of the systemic circulation) in four dogs was 4.5±0.6 ml/kg, or 100 ml for a 22-kg dog.
Discussion
The results of these studies demonstrate that alveolar hypoxia directly augments bronchopulmonary blood flow. This effect is due to local mechanisms in that it occurs in the absence of systemic hypoxemia, changes in systemic hemodynamics, and extrinsic neural influences. The bronchopulmonary shunt and its response to hypoxia can be surgically ablated by division of the bronchial vessels, and the magnitude of the response can be quantified.
Several observations support the conclusion that the observed changes in LA return with alveolar hypoxia represented changes in bronchopulmonary shunting, rather than changes in either pulmonary intravascular blood volume or extravascular fluid content. First, the net amount ofthis increased left atrial return after prolonged hypoxia in several dogs (120-200 ml, e.g, Fig.  4 ) approached the total pulmonary intravascular volume as estimated in these studies (100 ml) and as measured at comparable pressures by several other investigators (150-300 ml) (24-27). Although hypoxia has indeed been reported to decrease pulmonary intravascular volume (28, 29), it is unlikely that volume shunting occurred independent of any changes in pulmonary intra-and extravascular fluid content. Finally, and most important, the increased LA return with hypoxia was eliminated entirely by surgical interruption of the bronchial vessels. One could suggest that such manipulations somewhow interfere with the reactivity of the pulmonary compliance vessels. However, the response of the pulmonary vasculature to infused drugs (e.g., Fig. 6 ) is unchanged by division of the bronchial vessels.
The increase in bronchopulmonary shunting must be a local effect of the alveolar hypoxia itself. Reflex and neural mechanisms have been ruled out by the occurrence ofthe effect despite ganglionic blockade and vagotomy. Systemic blood Po2 and Pco2 were maintained constant. The major hemodynamic determinants ofbronchopulmonary shunt flow, namely aortic, PA, LA, and RA pressures were either held constant, or they changed in such a direction that would otherwise cause a decrease in bronchopulmonary flow. In fact, this last point demonstrates that the increased shunt must be due to an actual decrease in resistance to flow through the bronchopulmonary anastomoses.
The mechanism ofthe increase in bronchopulmonary shunt flow caused by alveolar hypoxi4 is not yet established. However, several aspects of the present studies suggest humoral mediation. The occurrence of systemic arterial dilatation beginning at just the time it takes blood from the pulmonary circulation to reach the systemic circuit in the present preparation suggests the liberation ofa dilating substance from the hypoxic pulmonary vasculature. The fact that ibuprofen and indomethacin given before the onset of hypoxia can not only abolish the increase in LA return but also attenuate this systemic dilatation implicates dilating prostaglandins. One possibility is that alveolar hypoxia induces, or increases, production by the lung vasculature of one or more vasodilating prostaglandins, which not only dilate the bronchopulmonary vessels but other systemic vessels as well. The identity of which, if any, dilating prostaglandins are released during alveolar hypoxia remains to be documented. A recent report (33) has documented increased levels of prostaglandin E2 in bronchopulmonary blood during cardiopulmonary bypass in humans; the state of aeration of the lungs during bypass in this latter study, i.e., whether they were left inflated or deflated, or whether they were ventilated, was not mentioned. The fact that less systemic vasodilatation occurred with the bronchial vessels divided than with an intact bronchial circulation might suggest that the bronchial and/or bronchopulmonary anastomotic vessels themselves are the site of production of the hypothesized vasodilating agent. However, since the bronchial vessels provide the vasa vasorum of the pulmonary vasculature, their elimination could affect any metabolic processes-such as prostaglandin production-carried out in the walls of the pulmonary vessels themselves.
An initially surprising finding in the present study was the lack of significant PA vasoconstriction in our preparation in response to alveolar hypoxia. In both humans (34) and dogs (35) (36) (37) there is wide variation among individuals in the strength of the pulmonary hypoxic pressor response. It has been demonstrated in dogs that (1) resting pulmonary tone is increased by administration of prostaglandin synthesis inhibitors (38, 39) and that (2) the PA hypoxic pressor response which is initially absent or weak in individual animals can be restored by inhibitors ofprostaglandin synthesis (35) (36) (37) . The increase in baseline mean PA and systemic arterial pressures and the restoration of the hypoxic pressor response by ibuprofen and indomethacin in our studies corroborate these findings and suggest the presence, even in the control state, of a circulating prostaglandin vasodilating agent. It is possible that the use of extracorporeal circulation and/or nonpulsatile pulmonary perfusion contributed to the production of such an agent. The association between the restoration of an active pulmonary hypoxic vasoconstrictor response with prostaglandin synthesis inhibition and the abolition of the hypoxia-induced increase in bronchopulmonary shunting might suggest a causal relationship between the two. At first glance this seems plausible, because, in general, an increase in PA pressure will tend to decrease bronchopulmonary shunt flow by increasing the "outflow pressure" of the. anastomotic channels. However, the conclusion that the two phenomena are separate effects of prostaglandin inhibition is supported by several observations. First, it is generally agreed that hypoxic pulmonary vasoconstriction occurs at the level of the small muscular pulmonary "arterioles" (2) , whereas the majority of the bronchopulmonary anastomoses are thought to be at the capillary level (10, 1 1); thus on anatomic grounds it could be concluded that hypoxic pulmonary vasoconstriction probably does not increase the outflow pressure of the bronchopulmonary shunts. Second, the gradual and progressive increase in PA pressure with hypoxia after prostaglandin administration (Figs. 7 and 8) should cause, using purely hemodynamic reasoning, a gradual and progressive decrease in bronchopulmonary flow; such an effect was not found. Finally, the hypoxia-induced increase in bronchopulmonary flow seen with pulmonary inflow arrested (Tables VI and VII) was abolished by prostaglandin inhibition. This last effect is, of course, independent of any changes in pulmonary artery pressure.
The finding that the LA return flow rate immediately after a period of alveolar hypoxia was actually less than the control rate, even after aortic pressure had recovered, is indicative of posthypoxic vasoconstriction of the bronchopulmonary anastomoses. This raises the interesting possibility that a vasoconstricting agent may be released, either during the period of alveolar hypoxia or upon recovery from hypoxia.
The magnitude of the increase in bronchopulmonary shunt flow seen in these studies, on the order of 3-4 ml/min, represents -20-50% of the total bronchopulmonary blood flow as measured by several other investigators (9, 13, 17) . With higher systemic pressure, the flow increase would be even larger (cf. Table  V) . Although one cannot extrapolate the absolute magnitude of the changes in bronchopulmonary shunt flow found in this study to the closed-chest, spontaneously breathing state, one would expect the changes in bronchopulmonary flow to be directionally similar. The amount of shunt flow in the present study would increase the bronchial contribution to anatomic right-to-left shunting, and thus to systemic desaturation, only marginally.
Likewise it would not produce any substantial increase in LV filling. However, the increased shunt flow could be expected to improve the nutrition of, and especially oxygen delivery to, the lung parenchyma and the small airway and vessel walls in those areas involved by consolidation, alveolar edema, or atelectasis. Moreover, the dilating effects of acute alveolar hypoxia on the bronchopulmonary anastomoses may be involved in the initial steps in the development ofthe sometimes massive enlargement of the bronchial circulation seen in such chronic hypoxic states as bronchiectasis.
